logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Bind Biosciences, Inc.

Calculating rank
USPTO Granted Patents = 12

% Expired Patents = 50.0


Forward Citations = 761

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Stephen E Zale (9 out of 50 patents)

silverMedal Greg Troiano (7 out of 41 patents)

bronzeMedal Mir Mukkaram Ali (7 out of 27 patents)

4.  James I Wright (5 out of 59 patents)

5.  Jeff Hrkach (4 out of 17 patents)

6.  Young-Ho Song (2 out of 19 patents)

7.  Christina Van Geen Hoven (2 out of 13 patents)

8.  Michael Figa (2 out of 9 patents)

9.  Abhimanyu Sabnis (2 out of 9 patents)

10.  David Dewitt (1 out of 10 patents)

11.  Luis Alvarez De Cienfuegos (1 out of 1 patent)


12 patents:

1. 8846077 - High throughput fabrication of nanoparticles (2014-09-30),
2. 8734846 - Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles (2014-05-27),
3. 8420123 - Drug loaded polymeric nanoparticles and methods of making and using same (2013-04-16),
4. 8357401 - Stable formulations for lyophilizing therapeutic particles (2013-01-22),
5. 8318211 - Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same (2012-11-27),
6. 8318208 - Drug loaded polymeric nanoparticles and methods of making and using same (2012-11-27),
7. 8293276 - Drug loaded polymeric nanoparticles and methods of making and using same (2012-10-23),
8. 8273363 - Cancer cell targeting using nanoparticles (2012-09-25),
9. 8246968 - Cancer cell targeting using nanoparticles (2012-08-21),
10. 8236330 - Cancer cell targeting using nanoparticles (2012-08-07),
11. 8211473 - Stable formulations for lyophilizing therapeutic particles (2012-07-03),
12. 8206747 - Drug loaded polymeric nanoparticles and methods of making and using same (2012-06-26),
Company Overview
Bind Biosciences, Inc., based in Cambridge, MA, specializes in the development of innovative therapeutics utilizing its proprietary nanoparticle technology. The company focuses on enhancing drug delivery systems to improve the efficacy and safety of treatments, particularly in the fields of oncology and other serious diseases. By leveraging advanced materials science and engineering, Bind aims to transform the way medications are administered, ultimately leading to better patient outcomes and more effective therapies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

12 Patents

#205 in Cambridge, MA

#1,549 in Massachusetts

#25,589 in US

#48,235 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Bind Biosciences, Inc.

Forward Citations = 761

11 inventors:

goldMedal Stephen E Zale (9 out of 50 patents)

silverMedal Greg Troiano (7 out of 41 patents)

bronzeMedal Mir Mukkaram Ali (7 out of 27 patents)

4.  James I Wright (5 out of 59 patents)

5.  Jeff Hrkach (4 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bind Biosciences, Inc.. Retrieved from https://idiyas.com/company/bind-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…